|Articles|November 1, 2005
Maximizing margin's meaning for melanoma
Atlanta — Recent developments in melanocyte-specific immunohistochemical stains are again proving that this technology, along with the proper technique, can enhance sensitivity in differentiating malignant melanoma from nevi in diagnostic specimens as well as in the interpretation of Mohs margins, according to Dirk M. Elston, M.D., here at the American Society for Dermatologic Surgery — American College of Mohs Micrographic Surgery and Cutaneous Oncology combined annual meeting.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Auricular Acupuncture for Facial Rejuvenation: Results from a Large Real-World Clinical Series
2
Sun Pharma’s Cosibelimab-ipdl (UNLOXCYT) Enters US Market for Advanced CSCC
3
Lebrikizumab Enters Late-Stage Testing for Nummular Eczema
4
Graham Heap, MBBS, PhD, Discusses Positive Phase 3 Results for Zasocitinib
5














